Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260585 · ClinicalTrials.gov registry record
Esophageal Cancer Risk Registry
A clinical trial of Esophageal Cancer and Hiatal Hernia, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT00260585 is a study of Esophageal Cancer and Hiatal Hernia that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 7,000 participants, above the 442-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (1484% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00260585, a study of Esophageal Cancer and Hiatal Hernia, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify markers in the blood and tissue that could indicate risk factors for the development and progression of esophagus cancer. This research aims to collect medical history, blood, and tissue samples from patients who present with an esophageal disorder. Identifying genetic and behavioral risk factors involved in the development of esophageal cancer might allow for early detection and prevention. Survival and an opportunity for a cure with esophageal cancer will depend greatly on the stage of diagnosis. Tumors can develop changes in their genetic (hereditary) make-up, and these changes can sometimes be seen in normal tissues before the development of cancer. These genetic (hereditary) changes can serve as tumor markers and can be detected using methods that study changes in genetic material like DNA and RNA. The analysis of proteins can provide additional information. By identifying changes in these molecules that are different or altered in cancer, the investigators can use methods and tests for the detection of these changes.
Conditions Studied
Interventions
- PROCEDURE Survey of client health, personal habits, family history
- PROCEDURE Blood specimen for non-DNA and DNA parts
- PROCEDURE Biopsy of esophageal/stomach tissue, lymph nodes, tumor
- PROCEDURE Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
Study Locations (1)
Pennsylvania
- Department of Cardiothoracic Surgery - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 1999-06 |
| Est. Completion | 2050-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260585
The ClinicalTrials.gov registry entry for NCT00260585 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 442-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (1484% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 4 interventions - of which Survey of client health, personal habits, family history is the first listed.
NCT00260585 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00260585 about?
NCT00260585 is a clinical study titled "Esophageal Cancer Risk Registry". The purpose of this study is to identify markers in the blood and tissue that could indicate risk factors for the development and progression of esophagus cancer. This research aims to collect medical history, blood, and tissue samples from patients who present with an esophageal disorder. Identifyi...
What is the current status of trial NCT00260585?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 1999-06. Estimated completion is 2050-12.
What conditions does trial NCT00260585 study?
This clinical trial studies the following conditions: Esophageal Cancer, Hiatal Hernia, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Esophageal Achalasia.
What interventions are being tested in trial NCT00260585?
The interventions under investigation include: Survey of client health, personal habits, family history (PROCEDURE), Blood specimen for non-DNA and DNA parts (PROCEDURE), Biopsy of esophageal/stomach tissue, lymph nodes, tumor (PROCEDURE), Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies (PROCEDURE).
Who is sponsoring clinical trial NCT00260585?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00260585 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.